Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę "Grabowska, Joanna" wg kryterium: Autor


Tytuł:
Stany Ja uczniów a spostrzeganie przez nich wybranych elementów obrazu własnego życia rodzinnego
Ego states of the Students and Their Perception of Chosen Elements of the Image of Own Family Life
Autorzy:
Grabowska, Joanna
Powiązania:
https://bibliotekanauki.pl/articles/445749.pdf
Data publikacji:
2017
Wydawca:
Uniwersytet Humanistyczno-Przyrodniczy im. Jana Długosza w Częstochowie. Wydawnictwo Uczelniane
Tematy:
analiza transakcyjna
stany Ja
spostrzeganie obrazu swojej rodziny przez uczniów
transactional analysis
ego states
students’ perception of their family
Opis:
Celem artykułu jest analiza wzajemnych związków pomiędzy obrazem rodziny pochodzenia a ujawnianymi stanami Ja osób badanych w ramach koncepcji analizy transakcyjnej. Przedstawiono zarys teorii Erica Berne’a opisujący analizę struktury stanów Ja: Rodzic Krytyczny, Rodzic Opiekuńczy, Dziecko Naturalne i Dziecko Przystosowane oraz Dorosły, wraz z zawartym w nim stanem Ethos i Pathos. Zaprezentowano przegląd literatury w zakresie związków rodziny pochodzenia z cechami jednostki podlegającymi jej oddziaływaniom w ujęciu systemowym typologii i relacji rodzinnych. Główne założenia badawcze dotyczące związków pomiędzy wybranymi parametrami rodziny a wynikającymi z koncepcji analizy transakcyjnej stanami Ja osób badanych potwierdziły się w zakresie związku pomiędzy spostrzeganym poziomem spójności i komunikacji w rodzinie oraz takimi stanami Ja, jak Pathos. Istotne statystycznie związki ze stanami Ja uzyskano dla wybranych właściwości matek i ojców. Ciekawym wynikiem jest obraz stanów Ja badanej młodzieży w postaci egogramu. Uzyskany profil wyników wykazuje wysoką zgodność z postulowanym w literaturze AT optymalnym dla funkcjonowania człowieka rozkładem stanów Ja. Przedstawione wnioski dotyczą badań porównawczych i praktycznych implikacji uzyskanych wyników dla procesu edukacji i wychowania oraz relacji nauczyciel–uczeń.
The aim of the paper is to analyse mutual relations between the perception of a biological family and ego states revealed by participants of a study conducted within the framework of Transactional Analysis. The analysis begins with the outline of Eric Berne’s concept regarding the structure of ego states: the Critical Parent, the Nurturing Parent, the Natural Child, the Adapted Child, the Adult, and Ethos and Pathos states. Next the paper reviews subject literature focused on the relations between a biological family and the features of a family member exposed to its influence from the perspective of family system typology and family relations. The main research assumptions regarding relations between selected parameters of a family and ego states described by TA were confirmed in the area of relations between the perceived level of consistency and communication in the family and the Pathos ego state. Statistically significant relations between ego states were obtained for selected features of mothers and fathers. The illustration of ego states of adolescents taking part in the study in the form of an egogram was an interesting outcome of the study. The results to a great extent confirm the distribution of ego states optimal for the functioning of an individual proposed in the TA literature. Conclusions suggest further comparative studies and practical implications of the results obtained for the educational process and teacher-student relations.
Źródło:
Edukacyjna Analiza Transakcyjna; 2017, 6; 191-212
2299-7466
Pojawia się w:
Edukacyjna Analiza Transakcyjna
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Therapy with liposomal doxorubicin in patients with advanced breast cancer after treatment with classical doxorubicin
Autorzy:
Kufel-Grabowska, Joanna
Powiązania:
https://bibliotekanauki.pl/articles/1065267.pdf
Data publikacji:
2015
Wydawca:
Medical Education
Tematy:
breast cancer
complications of oncological therapy
non-pegylated liposomal doxorubicin
Opis:
Breast cancer is the most common female cancer in the world and in Poland. The improvement of diagnostic and therapeutic methods has led to patients’ longer life expectancy. It has also made breast cancer a chronic disease, increasing the risk of late side effects of oncological therapy. More cardiovascular diseases are diagnose in patients over 65 with an oncological history than in those without it and therefore much effort must be made to maximise effectiveness of the therapy with as few side effects as possible. The article presents two breast cancer patients treated with big doses of liposomal doxorubicin with a good response and almost no side effects.
Źródło:
OncoReview; 2015, 5, 3; A103-108
2450-6125
Pojawia się w:
OncoReview
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
The use of fulvestrant in patients with advanced breast cancer
Autorzy:
Kufel-Grabowska, Joanna
Powiązania:
https://bibliotekanauki.pl/articles/1035843.pdf
Data publikacji:
2018
Wydawca:
Medical Education
Tematy:
breast cancer
fulvestrant
hormone therapy
Opis:
Breast cancer is the most common malignancy in women in Poland and the entire world, but thanks to early diagnostics and efficacious therapeutic methods, its prognosis is good. In some patients with advanced breast cancer, long-term survival is observed, which is why it is essential to select the most appropriate therapy, and to follow up on the course of disease and possible adverse events related to the treatment applied. The slow development of hormone-receptor-positive cancer, and a multitude of therapeutic options constitute a real challenge in palliative treatment. The use of fulvestrant resulted in a good response in both of the presented cases, and did not in any way comprise the daily lives of the patients over a long period of time.
Źródło:
OncoReview; 2018, 8, 1; 15-18
2450-6125
Pojawia się w:
OncoReview
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Cardiovascular complications of selected antibodies used in oncological immunotherapy
Autorzy:
Kufel-Grabowska, Joanna
Powiązania:
https://bibliotekanauki.pl/articles/1062897.pdf
Data publikacji:
2017
Wydawca:
Medical Education
Tematy:
bevacizumab
immunotherapy
monoclonal antibodies
pertuzumab
trastuzumab
trastuzumab-emtansine
vascular endothelial growth factor
Opis:
Immunotherapy supports other therapeutic methods and is an important element in the fight against cancer. Its main tasks include stimulation and guidance of the immune system to fight cancer, inhibition of the mechanisms that block the immune system, and direct destruction of neoplastic cells. Different from chemotherapy or hormonal therapy, its mechanism of action is associated with a different profile of adverse events. HER2 receptor inhibitors may cause symptoms of heart failure, which usually recede, once the treatment has been discontinued. Bevacizumab, an anti-VEGF antibody, induces numerous cardiovascular complications, including arterial hypertension, arterial embolism, haemorrhage and haemoptysis as well as venous thromboembolism.
Źródło:
OncoReview; 2017, 7, 2; 78-82
2450-6125
Pojawia się w:
OncoReview
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Fertility and breast cancer
Autorzy:
Kufel-Grabowska, Joanna
Powiązania:
https://bibliotekanauki.pl/articles/1064776.pdf
Data publikacji:
2016
Wydawca:
Medical Education
Tematy:
breast cancer during pregnancy
breast cancer in young women
fertility
fertility preservation strategies
Opis:
Breast cancer is the most common cancer among females worldwide. The mean age of breast cancer patients is > 60 yrs old, and it is seldom found in women < 40 yrs old (6.5%) and in very young women < 35 yrs old (0.6%). In young females, fertility and all its aspects are an additional therapeutic challenge. Before initiating treatment, the oncologist should offer effective contraception to be applied throughout the therapy, bearing in mind that fertility preservation is of utmost importance. When it comes to breast cancer in pregnancy, the attending physician should use a therapy which is safe for both the mother and the foetus. Chemotherapy, radiotherapy, hormonal therapy and immunotherapy can, to a lesser or greater degree, damage the ovarian function resulting in amenorrhea in women < 50 yrs (33–76%). However, owing to fertility preservation strategies, more and more pregnancies are successful, even in breast cancer survivors.
Źródło:
OncoReview; 2016, 6, 4; A157-161
2450-6125
Pojawia się w:
OncoReview
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
The young breast cancer patient therapy – new opportunities, new challenges
Autorzy:
Załuska-Kusz, Joanna
Kufel-Grabowska, Joanna
Powiązania:
https://bibliotekanauki.pl/articles/1035689.pdf
Data publikacji:
2019
Wydawca:
Medical Education
Tematy:
breast cancer in young patient
metastatic disease
non-pegylated liposomal doxorubicin
ribociclib
Opis:
The paper describes the case of a 31-year-old female patient with breast cancer with the abdominal metastases. This disease in young people usually has a more aggressive biological subtype, which significantly worsens the prognosis. In this patient aggressive treatment was used. It was effective and did not cause severe or long-term complications.
Źródło:
OncoReview; 2019, 9, 2; 51-54
2450-6125
Pojawia się w:
OncoReview
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Efficacy and safety of non-pegylated liposomal doxorubicin in metastatic breast cancer therapy
Autorzy:
Wójcik, Elżbieta
Kufel-Grabowska, Joanna
Gierba-Tomczyk, Joanna
Powiązania:
https://bibliotekanauki.pl/articles/1062503.pdf
Data publikacji:
2017
Wydawca:
Medical Education
Tematy:
breast cancer
non-pegylated liposomal doxorubicin
treatment
Opis:
Breast cancer is the most frequently diagnosed female cancer in Poland (over 17,500 women). Anthracyclines have become one of the most important drugs in breast cancer systemic treatment. In the treatment of metastatic disease combination chemotherapy with doxorubicin provides the objective response rate of 60–85%, and the median time of progression-free survival is about 12 months. Non-pegylated liposomal doxorubicin (NPLD) in combination with cyclophosphamide is associated with a lower risk of cardiotoxicity, higher efficacy and more favourable toxicity profile as compared with conventional anthracycline regimes. Two cases of females patients treated with NPLD described in this article demonstrate the importance of the choice of chemotherapy, professional monitoring, early detection and treatment of adverse effects. Non-pegylated liposomal doxorubicin ordained in systemic treatment of stage IV breast cancer prolongs survival and enhances the quality of life. It is a reasonable option for palliative therapy.
Źródło:
OncoReview; 2017, 7, 4; 162-167
2450-6125
Pojawia się w:
OncoReview
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Spectacular efficacy of neoadjuvant chemotherapy in a patient with cervical cancer of IB2 grade according to FIGO 2009
Spektakularna skuteczność chemioterapii neoadiuwantowej u pacjentki z rozpoznaniem raka szyjki macicy w stopniu IB2 według FIGO 2009 r.
Autorzy:
Kaźmierczak, Kamila
Nowakowski, Błażej
Kufel-Grabowska, Joanna
Cholewiński, Witold
Powiązania:
https://bibliotekanauki.pl/articles/1035650.pdf
Data publikacji:
2020
Wydawca:
Medical Education
Tematy:
cervical cancer
neoadjuvant chemotherapy
positron emission tomography
Opis:
The presented case report is an example of a spectacular effect of induction systemic treatment in a patient with locally advanced cervical cancer of IB2 grade according to FIGO 2009 (International Federation of Gynecologist and Obstetrician). The effect of induction chemotherapy (three series in paclitaxel/24 h + cisplatin regimen at an interval of three weeks) was the total metabolic response of the primary tumor and nodal lesions found in FDG-PET/CT (18F-fluorodeoxyglucose – positron emission tomography combined with computed tomography) as well as an image of total regression of the tumor in the obtained postoperative histopathological examination.
Przedstawiony opis przypadku jest przykładem spektakularnego efektu zastosowania chemioterapii neoadiuwantowej (NACT, neoadjuvant chemotherapy) u pacjentki z miejscowo zaawansowanym rakiem szyjki macicy w stopniu IB2 według FIGO 2009 r. (International Federation of Gynecologist and Obstetrician). Efektem zastosowanej chemioterapii indukcyjnej (trzech serii w schemacie paklitaksel/24 h + cisplatyna w odstępie 3-tygodniowym) była całkowita odpowiedź metaboliczna guza pierwotnego i zmian węzłowych stwierdzona w badaniu FDG-PET/CT (18F-fluorodeoksyglukoza – pozytonowa tomografia emisyjna połączona z tomografią komputerową), a także obraz całkowitej odpowiedzi patologicznej w otrzymanym pooperacyjnym badaniu histopatologicznym.
Źródło:
OncoReview; 2020, 10, 2; 69-76
2450-6125
Pojawia się w:
OncoReview
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Suspected ovarian cancer in a young patient with a congenital heart defect and a history of cardiac surgery and pacemaker implantation – difficult therapeutic decisions
Autorzy:
Kaźmierczak, Kamila
Stempniewski, Tomasz
Kufel-Grabowska, Joanna
Nowakowski, Błażej
Powiązania:
https://bibliotekanauki.pl/articles/1035815.pdf
Data publikacji:
2018
Wydawca:
Medical Education
Tematy:
Ca 125 marker
congenital heart defect
endometriosis
ovarian cancer
Opis:
After uterine cancer, ovarian cancer is the second most common female reproductive tract malignancy. In Poland, in 2015, there were 3735 new cases and 2738 deaths from ovarian cancer. Over 80% of all cases are diagnosed in women aged over 50, whereas only 6% – before 35 years of age. Most cases are diagnosed, when clinical symptoms have already appeared, and the disease is at least locally advanced. The case presented below describes a very young 28-year-old woman with a tumour in the pelvis, ascites and very high Ca 125 and HE 4 levels. The clinical symptoms as well as laboratory and imaging tests were suggestive of epithelial ovarian cancer that required urgent surgery due to progression of the disease. The surgery posed a significant risk of complications, but owing to the deterioration of the patient’s condition it was considered necessary. The patient was born with a severe, complex heart defect, had undergone two cardiac surgeries, and had a pacemaker (first VVIR, then DDD). She was also intensively treated for iatrogenic HCV infection and hypothyroidism. A multidisciplinary team (a gynecologist, cardiologist and anesthetist) were behind the decision to carry out a major gynecological operation which ended with success. For the past 6 years, the patient has been under constant oncological follow-up and enjoys a good health.
Źródło:
OncoReview; 2018, 8, 2; 38-41
2450-6125
Pojawia się w:
OncoReview
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Ocular side effects of the taxane-based chemotherapy – do only vascular disorders matter?
Autorzy:
Rzeszotarska, Anna
Stodolska-Nowak, Agata
Kufel-Grabowska, Joanna
Nowakowski, Błażej
Kocięcki, Jarosław
Powiązania:
https://bibliotekanauki.pl/articles/1035681.pdf
Data publikacji:
2019
Wydawca:
Medical Education
Tematy:
chemotherapy
ophthalmological complications
taxanes
Opis:
Taxanes, whose mechanism of action is based on blocking the cells’ division of cells, have been commonly used in the chemotherapy process for over two decades. The indications for the use of taxanes include ovarian cancer, breast cancer, lung cancer, prostate cancer, some of gastrointestinal malignant tumors or Kaposi sarcoma. Currently, chemotherapy based on taxanes, as well as every cytostatic medicine, allows to improve survival outcomes in many patients with diagnosed malignancies, although it also involves the occurrence of adverse effects. These adverse events may be life-threatening or at least they can decline the patient’s quality of life. The main aim of this paper is to feature possible ocular side effects during taxane based chemotherapy. Physicians taking care of patients during chemotherapy based on taxanes, as well as on every other cytostatic medicine, should be aware of these probable ocular complications. An early diagnosis of ophthalmic complications caused by chemotherapy makes it possible to avoid long-lasting adverse effects.
Źródło:
OncoReview; 2019, 9, 3; 59-63
2450-6125
Pojawia się w:
OncoReview
Dostawca treści:
Biblioteka Nauki
Artykuł

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies